Healthcare-associated infections surveillance report

Similar documents
Healthcare-associated infections surveillance report

Staph and MRSA Skin Infections Fact Sheet for Schools

Today s Agenda: 9/30/14

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts

Multi-Drug Resistant Organisms (MDRO)

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA)

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

Healthcare-associated Infections Annual Report December 2018

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

This coloring book from the Texas Department of State Health Services provides education for children related to antibiotic resistance.

MRSA Outbreak in Firefighters

Advice for those affected by MRSA outside of hospital If you have MRSA this booklet provides information to help manage your day-to-day life

About MRSA. MRSA (sometimes referred to as a superbug) stands for meticillin resistant Staphylococcus aureus.

running head: SUPERBUGS Humphreys 1

Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance. Ceredigion and Mid Wales Trust Data per Bed Days

Methicillin Resistant Staphylococcus aureus:

Advice for those affected by MRSA outside of hospital

A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Infection Control & Prevention

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

In-Service Training Program. Managing Drug-Resistant Organisms in Long-Term Care

Nosocomial Antibiotic Resistant Organisms

Nosocomial Antibiotic Resistant Organisms MRSA & VRE

Healthcare-associated Infections Annual Report

Healthcare-associated Infections Annual Report March 2015

MRSA. Patient Screening Information

Methicillin-Resistant Staphylococcus aureus

MRSA Screening (Elective Patients)

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

Two (II) Upon signature

Understanding MRSA. 1. MRSA: An Overview The Rise of Antibiotic-Resistant Infections MRSA Infections Are Increasing 30 Among Teenagers

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

MRSA: How to Keep This Deadly Super Bug From Infecting You

Carbapenemase-Producing Enterobacteriaceae (CPE)

Infection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

Prevalence & Risk Factors For MRSA. For Vets

Source: Portland State University Population Research Center (

Clinic Infectious Disease Control

Staphylococcus aureus β. r r

Hospital Infection. Mongolia, October Walter Popp Hospital Hygiene University Clinics Essen, Germany

Clinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH?

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual)

Hand Hygiene Policy. January Hand Hygiene Policy and Procedure (an element of Standard Infection Control Precautions)

Summary of the latest data on antibiotic resistance in the European Union

MRSA. by Melissa Ochs

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process

Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA)

EcoHydra Antimicrobial Handwash. Product Overview. Physical Properties. Product Description. Regulatory Compliance. Key Features and Benefits

Prospectus Presentation

Can you treat mrsa with amoxicillin

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Summary Report Relating to a Pilot Program to Require Reporting of Methicillin-resistant Staphylococcus aureus

IOWA HIGH SCHOOL ATHLETIC ASSOCIATION REVIEW OF BLOOD-BORNE PATHOGEN PROCEDURES

The Rise of MRSA. The term staph infection is a relatively common phrase

Staphylococcus aureus and Health Care associated Infections

So Why All the Fuss About Hand Hygiene?

Tackling MRSA 1. Running head: TACKLING MRSA. Tackling MRSA

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

NHS GRAMPIAN MRSA POLICY FOR COMMUNITY SETTINGS JUNE 2003

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Clorox Germicidal Wipes & Spray. The Easy & Most Effective Way to Disinfect

The Core Elements of Antibiotic Stewardship for Nursing Homes

FM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...

Version Control Sheet

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

Concise Antibiogram Toolkit Background

Horizontal vs Vertical Infection Control Strategies

Conflict of interest: We have no conflict of interest to report on this topic of SSI reduction for total knees.

Operational Directives

MRSA Screening Programme National Targeted Rollout. MRSA Screening

: "INFECTION CONTROL: WHAT'S COMING IN 2017?" LISA THOMAS RN-BC STATE TRAINING COORDINATOR OFFICE OF LONG TERM CARE

COMMISSION OF THE EUROPEAN COMMUNITIES

Other Enterobacteriaceae

Screening for MRSA / MSSA and CPO within the Kent Kidney Care Centre

Antimicrobial Stewardship

Healthcare-associated Infections and Antimicrobial Use Prevalence Survey

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

The Spread of the Superbug

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

Issue Date: Veterinary Technician January 2009 (Vol 30, No 1)

Reportable Disease Surveillance & Antibiotic Resistant Bacteria

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Cleaning & Sanitising Medical range. Working in harmony with nature to protect

Surveillance of Multi-Drug Resistant Organisms

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

Antibiotic stewardship in long term care

Antimicrobial resistance (EARS-Net)

Transcription:

Healthcare-associated infections surveillance report Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q3 of 2017/18 Summary Table Q3 2017/18 Previous quarter (Q2 2017/18) Same quarter of previous year (Q3 2016/17) March 2018 Year-todate 2017/18 Total new MRSA cases identified 762 756 716 2,134 Number of new MRSA cases associated with the reporting facility 331 359 357 969 Total inpatient days 726,096 690,507 715,803 2,060,870 Rate of MRSA associated with the reporting facility per 10,000 inpatient days (95% CI) Highlights 4.6 (4.1-5.1) 5.2 (4.7-5.8) 5.0 (4.5-5.5) 4.7 (4.4-5.0) The provincial rate of new MRSA cases associated with the reporting facility in Q3 2017/18 was 4.6 per 10,000 inpatient days, which was lower than the previous quarter (5.2 per 10,000 inpatient days). However, the difference was not statistically significant. The MRSA rate in Q3 of 2017/18 was not significantly different from the same quarter of the previous year (5.0 per 10,000 inpatient days in Q3 of 2016/17). The provincial rate of MRSA has not changed significantly from Q1 of 2013/2014 to Q3 of 2017/2018. What is Methicillin-resistant Staphylococcus aureus (MRSA)? MRSA is a type of Staph bacteria that has become resistant to many antibiotics, including methicillin, penicillin, and amoxicillin, and is thus more difficult to treat. MRSA often lives on the skin or in the nose of healthy people without causing symptoms (this is called colonization). It can, however, cause skin and other infections. Most infections are minor, such as pimples and boils. Serious infections such as severe wound infections, pneumonia, or septicaemia (infection in the bloodstream) can result in life-threatening illness or, if left untreated, death. Those with weakened immune systems and chronic illnesses are more susceptible to developing an infection. How is MRSA transmitted? MRSA is primarily spread by skin-to-skin contact or through contact with surfaces contaminated with the bacteria. About 2 in 100 people in the community carry MRSA. People who carry MRSA but do not have signs of infection can spread the bacteria to others. It has shown to spread easily in healthcare settings; therefore hospital patients and residents in residential care facilities are at a higher risk of acquiring MRSA. How to prevent MRSA transmission? Clean your hands often with soap and water or use an alcohol-based hand rub (sanitizer); do not share personal items; cover your wounds or cuts with clean, dry bandages until healed; and wash used sheets, towels, and clothes with warm water and laundry detergent. The spread of MRSA can be prevented in healthcare settings through adherence to infection control measures such as contact precautions, careful cleaning of patient rooms and medical equipment, and good hand hygiene on the part of physicians, nursing staff, and other healthcare providers.

Why is MRSA being monitored in BC hospitals? MRSA bacteria have many virulence factors that enable them to cause disease. For example, MRSA is a cause of healthcare-associated bloodstream and catheter-related infections. MRSA is also a common cause of community-associated infections, especially skin and soft tissue infections, and can also cause necrotizing pneumonia. Active surveillance (e.g., screening of high-risk individuals) can identify patients colonized with MRSA so that precautions can be taken to prevent transmission to other patients. Where to find information about MRSA The PICNet website (www.picnet.ca) provides provincial guidance, toolkits, and related resources for the prevention and control of MRSA and other antimicrobial organisms, as well as the surveillance protocol and reports on MRSA in BC. If you have questions or suspect that you have MRSA, please contact your doctor or healthcare provider. This quarterly update presents the latest data on the incidence and trends of healthcare-associated (HCA) cases of MRA that were newly identified among inpatients in the last five years. In the following graphs, 1) MRSA cases that were associated with another healthcare facility, community-associated, or of unknown origin were not included. 2) The data were aggregated by fiscal quarter for each health authority except Provincial Health Services Authority (PHSA), which aggregated the data by calendar quarter. The time frame of each fiscal quarter varied by fiscal year and there were more days in the fourth quarter (Q4) than in other three quarters (Q1, Q2, and Q3) of each fiscal year. 3) The line in each graph represents the overall linear trend over time. 4) Direct comparison of the number of cases or the rate between health authorities is not recommended due to variations in case finding strategies and the application of MRSA case classification for surveillance among the health authorities. Figure 1. Provincial rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter, 2013/14-2017/18, British Columbia Provincial Infection Control Network of British Columbia (PICNet) Page 2 of 6

Figure 2. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter, 2013/14-2017/18, Interior Health Figure 3. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter, 2013/14-2017/18, Fraser Health Provincial Infection Control Network of British Columbia (PICNet) Page 3 of 6

Figure 4. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter, 2013/14-2017/18, Vancouver Coastal Health 1 Figure 5. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter, 2013/14-2017/18, Island Health 2 1 Includes acute care facilities of Providence Health Care (PHC) 2 The data include two new hospitals opened during Q3 of 2017/18 and historical data from two closed hospitals. Provincial Infection Control Network of British Columbia (PICNet) Page 4 of 6

Figure 6. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter, 2013/14-2017/18, Northern Health Figure 7. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and calendar quarter, 2013/14-2017/18, Provincial Health Services Authority Provincial Infection Control Network of British Columbia (PICNet) Page 5 of 6

Provincial Infection Control Network of BC (PICNet) 1001 West Broadway, Suite 504 Vancouver, BC V6H 4B1 Tel: 604-875-4844 x 22985 Fax: 604-875-4373 Website: www.picnet.ca Email: picnet@phsa.ca Disclaimer The purpose of this report is to provide information to healthcare providers, decision-makers, patients, and the public on healthcare-associated infections identified among the patients admitted to acute care facilities. This report may be used, in whole or in part, as the basis for infection prevention and control practices to improve the quality of healthcare services. PICNet does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information in the report; neither does it intend to provide specific medical advice. Commercial uses are prohibited without express written permission.